A challenge confronting the Food and Drug Administration — and other regulators around the world — is how to regulate generative AI. The approach it uses for new drugs and devices isn’t appropriate.
Original Image Link
Source:hbr.org
Original Image Link
Source:hbr.org
Posted: 2024-09-04 07:54:00